Where can I read HISAMITSU PHARMACEUTICAL CO.,INC.'s disclosures in English?
Pulse News Wire translates all TDNet filings for HISAMITSU PHARMACEUTICAL CO.,INC. (4530.T) to English. 3 disclosures have been translated since Jan 14, 2026.
How many disclosures has HISAMITSU PHARMACEUTICAL CO.,INC. filed on TDNet?
Pulse News Wire has translated 3 disclosures for HISAMITSU PHARMACEUTICAL CO.,INC. since Jan 14, 2026.
Does HISAMITSU PHARMACEUTICAL CO.,INC. publish English IR materials?
No. HISAMITSU PHARMACEUTICAL CO.,INC. is listed on the PRIME Market and has no English disclosure requirement. Pulse News Wire is the only English-language source for these filings.
What types of disclosures has HISAMITSU PHARMACEUTICAL CO.,INC. filed?
HISAMITSU PHARMACEUTICAL CO.,INC. has filed the following types of disclosures on TDNet: M&A (2), ETF (1).
English translations for all 4,436 JPX-listed companies.
Including the 2,300 Standard and Growth Market companies with no other English source.
